MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

COVID-19

Home
COVID-19
COVID Infection multiple sclerosis

COVID-19 Infection and Multiple Sclerosis

MStranslate
March 14, 2023
COVID-19, Infection, Research
MStranslate co-founder, Brett Drummond, explores and explains a recently published research paper that has identified COVID-19 infection as a potential trigger for multiple sclerosis. While the outcomes of...
COVID-19 vaccine

Multiple Sclerosis and the COVID-19 Vaccine

MStranslate
January 12, 2022
COVID-19, Dr Sally Shaw, Infection
5 Comments
UPDATED I don’t think it would be much of a stretch to say that the last two years have been dominated by the coronavirus pandemic.  In a continually changing environment, we have recognised the need to...
COVID-19 vaccines

Community Q&A: COVID-19 Vaccines & MS

MStranslate
September 29, 2021
Community, COVID-19, Q&A, Research
1 Comment
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, it looks at the latest...
lockdown fatigue

Not MS Fatigue, but Lockdown Fatigue: Dr Sally Shaw

MStranslate
August 13, 2021
COVID-19, Dr Sally Shaw, Infection, Mental Health, Symptoms
By Dr Sally Shaw. Lockdown is a strange beast isn’t it?  Whether you are flat out on Zoom, or staring at the ceiling between Netflix episodes, most people are reporting high levels of ‘over it’ and...
AstraZeneca Vaccine

Safety of AstraZeneca COVID-19 Vaccine in PwMS

MStranslate
June 7, 2021
COVID-19, Infection, Research, Treatments
2 Comments
One of the most common questions that I have received from the MStranslate community lately is whether there is any new information about the COVID vaccines for people living with multiple sclerosis. Last...
resilience

Resilience, the Pandemic & MS: Dr Sally Shaw

MStranslate
May 18, 2021
COVID-19, Dr Sally Shaw, Infection, Mental Health, Quality of Life, Symptoms
1 Comment
From the psychologist’s perspective: When the COVID-19 pandemic started and we knew we were in for lockdown in Melbourne, I worried that PwMS would shy away from continuing psychological support.  I...

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.